TP53 and malignant colon neoplasm: We assessed the effects of decitabine on the regulation of DNMT1, cell cycle, cell proliferation and programmed cell death, and compared the drug treatment effects in p53 null and wild-type human colon cell lines and imaged the growth of EdU-labeled colon cancer cells by fluorescence microscopy.